Does NADOLOL Cause Vaginal flatulence? 174 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Vaginal flatulence have been filed in association with NADOLOL (Nadolol). This represents 9.3% of all adverse event reports for NADOLOL.
174
Reports of Vaginal flatulence with NADOLOL
9.3%
of all NADOLOL reports
0
Deaths
173
Hospitalizations
How Dangerous Is Vaginal flatulence From NADOLOL?
Of the 174 reports, 173 (99.4%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Vaginal flatulence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NADOLOL. However, 174 reports have been filed with the FAERS database.
What Other Side Effects Does NADOLOL Cause?
Drug ineffective (989)
Macular degeneration (781)
Off label use (330)
Weight decreased (324)
Nausea (295)
Dyspepsia (263)
Abdominal pain (259)
Therapeutic product effect incomplete (251)
Pain (244)
Malaise (241)
What Other Drugs Cause Vaginal flatulence?
METRONIDAZOLE (230)
ACETAMINOPHEN (219)
HYDROMORPHONE (218)
ADALIMUMAB (207)
SULFAMETHOXAZOLE\TRIMETHOPRIM (205)
MESALAMINE (198)
MORPHINE (191)
HYDROCORTISONE (184)
BISACODYL (182)
ATORVASTATIN (181)
Which NADOLOL Alternatives Have Lower Vaginal flatulence Risk?
NADOLOL vs NADROPARIN
NADOLOL vs NAFARELIN
NADOLOL vs NAFCILLIN
NADOLOL vs NAFCILLIN\NAFCILLIN
NADOLOL vs NAFRONYL